Exploring logotherapy's effects on mood disorders in adolescents
The Effects of Logotherapy on Meaning in Life, Depression, Anxiety and Suicidal Ideation in Adolescents With Mood Disorders
This study is testing if logotherapy can help improve mood and reduce feelings of depression and anxiety in teenagers with mood disorders.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 15 Years to 24 Years |
| Sex | All |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Kaohsiung City, Niaosong District) |
| Trial ID | NCT05797428 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of logotherapy on adolescents diagnosed with mood disorders, focusing on its effects on meaning in life, depression, anxiety, and suicidal ideation. Over a two-year period, 120 participants will be recruited from outpatient psychiatric clinics and will undergo a single-blind randomized controlled trial. The study will utilize four assessment tools to measure changes in mental health outcomes. The goal is to provide insights into how logotherapy can help improve the psychological well-being of adolescents facing these challenges.
Who should consider this trial
Good fit: Ideal candidates are adolescents diagnosed with mood disorders who exhibit mild to moderate depression and are willing to participate in logotherapy.
Not a fit: Patients with severe emotional disorders or those exhibiting serious suicidal ideation may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a new therapeutic approach to help adolescents with mood disorders find meaning in life and reduce suicidal thoughts.
How similar studies have performed: While logotherapy has been explored in various contexts, this specific focus on adolescents with mood disorders and its effects on anxiety and suicidal ideation is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with mood disorders (such as depression, bipolar disorder) diagnosed by a psychiatrist. * Patient Health Questionnaire-9 items (PHQ-9) score 5-19 points (indicating mild depression to moderate to severe depression) * Agree to participate in logotherapy * Able to participate in logotherapy Exclusion Criteria: * Patients with severe emotional disorders who cannot participate in logotherapy. * Those who have severe psychopathological phenomena and cannot judge reality or those who are mentally deficient. * Those who have serious suicidal ideation or clear suicide plan are not suitable for interview
Where this trial is running
Kaohsiung City, Niaosong District
- Kaohsiung Chang Gung Memorial Hospital — Kaohsiung City, Niaosong District, Taiwan (Recruiting)
Study contacts
- Study coordinator: Fan-Ko Sun, PhD
- Email: sunfanko@ntu.edu.tw
- Phone: +886-2-33669702
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.